• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾病患者肾功能下降与出汗量减少有关。

Decline of kidney function is associated with lower sweat weight in patients with chronic kidney disease.

作者信息

Shoumariyeh Tarik, Logar Florian, Helk Oliver, Hofer Johannes, Schmetterer Klaus G, Mersi Brigitte, Gruber Saskia, Säemann Marcus D, Kaltenecker Christopher C, Kovarik Johannes J

机构信息

Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, General Hospital of Vienna, Vienna, Austria.

Department of Ophthalmology, Academic Teaching Hospital of St. John of God, Vienna, Austria.

出版信息

Sci Rep. 2025 Jul 2;15(1):22518. doi: 10.1038/s41598-025-05855-8.

DOI:10.1038/s41598-025-05855-8
PMID:40596012
Abstract

Excretion of sodium and water through the skin as sweat represents a regulatory mechanism of electrolyte- and fluid balance. Since patients with chronic kidney disease (CKD) exhibit increased skin sodium content, we investigated the feasibility of sweat testing as a novel experimental tool to provide a more complete assessment of fluid- and sodium status. In this cross-sectional feasibility study, we applied pilocarpine iontophoresis to induce sweat testing in 58 patients across various stages of CKD including kidney transplant recipients and a healthy control cohort (n = 6) to investigate possible effects of CKD and transplantation status on sweat weight and sodium concentration. Due to non-linear relationships, we modeled our data using polynomial regression. Decline of kidney function showed a significant association with lower sweat weight: adj R = 0.2278, F(2, 61) = 10.29, p = 0.0001. Sweat sodium concentrations were increased in moderate CKD, however, this effect was lost in end-stage kidney disease with and without requirement of hemodialysis: adj R = 0.3701, F(4, 59) = 10.26, p = 2.261e-06. Diagnostic sweat analysis represents an innovative, non-invasive option for a more thorough investigation of sodium- and fluid homeostasis in CKD. Lower sweat weight and higher sweat sodium concentrations represent a unique feature of CKD patients with potential therapeutic implications.Trial registration: This study is registered at ClinTrials.gov with the study number NCT06354842.

摘要

通过皮肤以汗液形式排泄钠和水是电解质和液体平衡的一种调节机制。由于慢性肾脏病(CKD)患者的皮肤钠含量增加,我们研究了汗液检测作为一种新型实验工具的可行性,以更全面地评估液体和钠的状态。在这项横断面可行性研究中,我们应用毛果芸香碱离子导入法对58例不同阶段的CKD患者(包括肾移植受者)和一个健康对照队列(n = 6)进行汗液检测,以研究CKD和移植状态对汗液重量和钠浓度的可能影响。由于存在非线性关系,我们使用多项式回归对数据进行建模。肾功能下降与较低的汗液重量显著相关:调整R = 0.2278,F(2, 61) = 10.29,p = 0.0001。中度CKD患者的汗液钠浓度升高,然而,在终末期肾病患者中,无论是否需要血液透析,这种效应都消失了:调整R = 0.3701,F(4, 59) = 10.26,p = 2.261e - 06。诊断性汗液分析是一种创新的、非侵入性的方法,可用于更深入地研究CKD患者的钠和液体稳态。较低的汗液重量和较高的汗液钠浓度是CKD患者的独特特征,可能具有治疗意义。试验注册:本研究已在ClinicalTrials.gov注册,研究编号为NCT06354842。

相似文献

1
Decline of kidney function is associated with lower sweat weight in patients with chronic kidney disease.慢性肾病患者肾功能下降与出汗量减少有关。
Sci Rep. 2025 Jul 2;15(1):22518. doi: 10.1038/s41598-025-05855-8.
2
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在患有早期(1 至 3 期)非糖尿病慢性肾脏病的成人中的应用。
Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3.
3
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.性别作为肾移植后同种异体移植及患者相关预后的预测因素。
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2.
4
Serum and urine nucleic acid screening tests for BK polyomavirus-associated nephropathy in kidney and kidney-pancreas transplant recipients.肾移植和肾胰联合移植受者中BK多瘤病毒相关性肾病的血清和尿液核酸筛查试验
Cochrane Database Syst Rev. 2024 Nov 28;11(11):CD014839. doi: 10.1002/14651858.CD014839.pub2.
5
Altered dietary salt intake for preventing diabetic kidney disease and its progression.改变膳食盐摄入量以预防糖尿病肾病及其进展。
Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD006763. doi: 10.1002/14651858.CD006763.pub3.
6
Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women.用低钠盐替代物(LSSS)代替盐以促进成年人、儿童和孕妇的心血管健康。
Cochrane Database Syst Rev. 2022 Aug 10;8(8):CD015207. doi: 10.1002/14651858.CD015207.
7
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
8
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂用于患有早期(1至3期)非糖尿病慢性肾病的成人。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007751. doi: 10.1002/14651858.CD007751.pub2.
9
Arterial Stiffness and Subsequent Incidence of CKD and Kidney Function Decline in a Large Longitudinal Community Cohort: The Atherosclerosis in Communities (ARIC) Study.大型纵向社区队列中动脉僵硬度与慢性肾脏病的后续发病率及肾功能下降:社区动脉粥样硬化风险(ARIC)研究
Am J Kidney Dis. 2025 Jul;86(1):32-42. doi: 10.1053/j.ajkd.2024.11.011. Epub 2025 Jan 23.
10
Dietary interventions for adults with chronic kidney disease.针对成年慢性肾病患者的饮食干预措施。
Cochrane Database Syst Rev. 2017 Apr 23;4(4):CD011998. doi: 10.1002/14651858.CD011998.pub2.

本文引用的文献

1
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.KDIGO 2024慢性肾脏病评估与管理临床实践指南
Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
2
The correlation of urea and creatinine concentrations in sweat and saliva with plasma during hemodialysis: an observational cohort study.血液透析过程中汗液和唾液与血浆中尿素和肌酐浓度的相关性:一项观察性队列研究。
Clin Chem Lab Med. 2024 Jan 23;62(6):1118-1125. doi: 10.1515/cclm-2023-1285. Print 2024 May 27.
3
The role of intra- and interdialytic sodium balance and restriction in dialysis therapies.
透析期间及透析间期钠平衡与限制在透析治疗中的作用
Front Med (Lausanne). 2023 Dec 4;10:1268319. doi: 10.3389/fmed.2023.1268319. eCollection 2023.
4
Enhancing Sweat Rate Using a Novel Device for the Treatment of Congestion in Heart Failure.使用一种新型装置提高出汗率以治疗心力衰竭中的充血
Circ Heart Fail. 2023 Jan;16(1):e009787. doi: 10.1161/CIRCHEARTFAILURE.122.009787. Epub 2022 Nov 2.
5
Outcomes and predictors of skin sodium concentration in dialysis patients.透析患者皮肤钠浓度的结果与预测因素
Clin Kidney J. 2022 Jan 28;15(6):1129-1136. doi: 10.1093/ckj/sfac021. eCollection 2022 Jun.
6
The roles of sodium and volume overload on hypertension in chronic kidney disease.钠和容量超负荷在慢性肾脏病高血压中的作用。
Kidney Res Clin Pract. 2021 Dec;40(4):542-554. doi: 10.23876/j.krcp.21.800. Epub 2021 Nov 17.
7
Hypertension due to loss of water.因失水导致的高血压
Acta Physiol (Oxf). 2021 Jun;232(2):e13658. doi: 10.1111/apha.13658. Epub 2021 Apr 18.
8
Aestivation motifs explain hypertension and muscle mass loss in mice with psoriatic skin barrier defect.夏季休眠图案解释了银屑病皮肤屏障缺陷小鼠的高血压和肌肉质量损失。
Acta Physiol (Oxf). 2021 May;232(1):e13628. doi: 10.1111/apha.13628. Epub 2021 Feb 23.
9
Adaptive physiological water conservation explains hypertension and muscle catabolism in experimental chronic renal failure.适应性生理水合作用解释了实验性慢性肾衰竭中的高血压和肌肉分解代谢。
Acta Physiol (Oxf). 2021 May;232(1):e13629. doi: 10.1111/apha.13629. Epub 2021 Mar 7.
10
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.KDIGO 2020慢性肾脏病糖尿病管理临床实践指南
Kidney Int. 2020 Oct;98(4S):S1-S115. doi: 10.1016/j.kint.2020.06.019.